Detalhe da pesquisa
1.
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients.
Clin Exp Rheumatol
; 41(1): 60-66, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349415
2.
Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.
Clin Exp Rheumatol
; 40(5): 1006-1010, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238750
3.
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.
Clin Exp Rheumatol
; 39(5): 1085-1092, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33427618
4.
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
JAMA
; 306(7): 711-20, 2011 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21846852
5.
Pegloticase treatment of chronic refractory gout: Update on efficacy and safety.
Semin Arthritis Rheum
; 50(3S): S31-S38, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620200
6.
Development of a multivariable improvement measure for gout.
Arthritis Res Ther
; 22(1): 164, 2020 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600452
7.
Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase.
J Rheumatol
; 47(4): 605-612, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31203212
8.
Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout.
Hypertension
; 74(1): 95-101, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079535
9.
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
Arthritis Res Ther
; 20(1): 286, 2018 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30594229
10.
Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.
Arthritis Res Ther
; 19(1): 191, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818095
11.
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Arthritis Res Ther
; 16(2): R60, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24588936